Home
Live Updates
Laurus Labs invests in ImmunoACT to acquire additional stake of 7.24% : comparemela.com
Laurus Labs invests in ImmunoACT to acquire additional stake of 7.24%
Post the completion of the deal, Laurus Labs’ stake in ImmunoACT will increase to 33.86% on fully diluted basis.
Related Keywords
India ,
United States ,
Mumbai ,
Maharashtra ,
American ,
Satyanarayana Chava ,
Rahul Purwar ,
Laurus Lab ,
Immunoadoptive Cell Therapy Private ,
American Society Of Hematology ,
Laurus Labs ,
Immunoadoptive Cell Therapy Private Limited ,
Navi Mumbai ,
Tata Memorial ,
American Society ,
Gene Therapy ,
Chief Executive ,
Indian Patients ,
Lauruslab ,
Investment ,
Immunoact ,
Stakes ,
Business ,
comparemela.com © 2020. All Rights Reserved.